{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:17:32Z","timestamp":1787163452573,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11655-024-3768-7","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T22:18:22Z","timestamp":1734733102000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and Safety of Juan Bi Pill with Add-on Methotrexate in Active Rheumatoid Arthritis: A 48-Week, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1007","volume":"31","author":[{"given":"Qing-yun","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-chun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-mei","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-qian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"3768_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clim.2018.04.001","volume":"206","author":"VL Bui","year":"2019","unstructured":"Bui VL, Brahn E. Cytokine targeting in rheumatoid arthritis. Clin Immunol 2019;206:3\u20138.","journal-title":"Clin Immunol"},{"key":"3768_CR2","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016;388:2023\u20132038.","journal-title":"Lancet"},{"key":"3768_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.berh.2018.10.005","volume":"32","author":"D van der Woude","year":"2018","unstructured":"van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2018;32:174\u2013187.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3768_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z","volume":"42","author":"SE Gabriel","year":"1999","unstructured":"Gabriel SE, Crowson CS, O\u2019Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955\u20131985. Arthritis Rheum 1999;42:415\u2013420.","journal-title":"Arthritis Rheum"},{"key":"3768_CR5","first-page":"526","volume":"17","author":"YS Zhou","year":"2013","unstructured":"Zhou YS, Wang XR, An Y, Li C, Zhang XY, Duan TJ, et al. A multicenter study of deformity and disability in rheumatoid arthritis patients in China. Chin J Rheumatol (Chin) 2013;17:526\u2013532.","journal-title":"Chin J Rheumatol (Chin)"},{"key":"3768_CR6","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/1756-185X.12573","volume":"20","author":"B Su","year":"2017","unstructured":"Su B, Ma Q, Edwards CJ, Williams M, Adams J. Characteristics of hand involvement in a comparative study of two early RA cohorts from the UK and China. Int J Rheum Dis 2017;20:1426\u20131436.","journal-title":"Int J Rheum Dis"},{"key":"3768_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrrheum.2017.95","volume":"13","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Bijlsma JWJ, Cutolo M, McInnes IB. Managing rheumatic and musculoskeletal diseases\u2014past, present and future. Nat Rev Rheumatol 2017;13:443\u2013448.","journal-title":"Nat Rev Rheumatol"},{"key":"3768_CR8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/annrheumdis-2016-210711","volume":"76","author":"K Chatzidionysiou","year":"2017","unstructured":"Chatzidionysiou K, Emamikia S, Nam J, Ramiro S, Smolen J, et al. Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2017;76:1102\u20131107.","journal-title":"Ann Rheum Dis"},{"key":"3768_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landew\u00e9 R, Bijlsma J, Burmester G, Chatzidionysiou K, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76:960\u2013977.","journal-title":"Ann Rheum Dis"},{"key":"3768_CR10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/S0140-6736(19)30768-8","volume":"393","author":"A Molt\u00f3","year":"2019","unstructured":"Molt\u00f3 A, Dougados M. Novel DMARD monotherapy in rheumatoid arthritis. Lancet 2019;393:2277\u20132278.","journal-title":"Lancet"},{"key":"3768_CR11","doi-asserted-by":"publisher","first-page":"102398","DOI":"10.1016\/j.autrev.2019.102398","volume":"18","author":"A Rubbert-Roth","year":"2019","unstructured":"Rubbert-Roth A, Szab\u00f3 MZ, Kedves M, Nagy G, Atzeni F, Sarzi-Puttini P. Failure of anti-TNF treatment in patients with rheumatoid arthritis: the pros and cons of the early use of alternative biological agents. Autoimmun Rev 2019;18:102398.","journal-title":"Autoimmun Rev"},{"key":"3768_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s11655-015-2305-0","volume":"21","author":"QQ Liang","year":"2015","unstructured":"Liang QQ, Shi Q, Wood RW, Xing LP, Wang YJ. Peri-articular lymphatic system and \u201cBi\u201d theory of Chinese medicine in the pathogenesis and treatment of arthritis. Chin J Integr Med 2015;21:648\u2013655.","journal-title":"Chin J Integr Med"},{"key":"3768_CR13","first-page":"812","volume":"41","author":"XH Gu","year":"2021","unstructured":"Gu XH, Chen P, Zhu L, Zou X, Zhou Y, Du HL, et al. Efficacy observation of Juanbi Decoction adjuvant therapy for active stage rheumatoid arthritis. Chin J Integr Tradit West Med (Chin) 2021;41:812\u2013816.","journal-title":"Chin J Integr Tradit West Med (Chin)"},{"key":"3768_CR14","first-page":"165","volume":"23","author":"J Li","year":"2017","unstructured":"Li J, Rong B, Jia J, Pan MZ. Effects of the addition and subtraction of the Juan Bi Tang on inflammatory factors, serum MMP-3, OPG and RANKL in the synovial fluid of patients with rheumatoid arthritis with wind-cold-damp paralysis. Chin J Exp Tradit Med Formul (Chin) 2017;23:165\u2013170.","journal-title":"Chin J Exp Tradit Med Formul (Chin)"},{"key":"3768_CR15","first-page":"16","volume":"40","author":"ZJ Liang","year":"2024","unstructured":"Liang ZJ, Xiao R. Clinical observation of the addition and subtraction of the Juan Bi Tang in the treatment of rheumatoid arthritis in the active stage. Shanxi J Tradit Chin Med (Chin) 2024;40:16\u201318.","journal-title":"Shanxi J Tradit Chin Med (Chin)"},{"key":"3768_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fphar.2020.00045","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Jia Q, Chen T, Yin H, Tian X, et al. Alleviation of synovial inflammation of Juanbi-Tang on collagen-induced arthritis and TNF-Tg mice model. Front Pharmacol 2020;11:45.","journal-title":"Front Pharmacol"},{"key":"3768_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ijsu.2011.09.004","volume":"9","author":"KF Schulz","year":"2011","unstructured":"Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 2011;9:672\u2013677.","journal-title":"Int J Surg"},{"key":"3768_CR18","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569\u20132581.","journal-title":"Arthritis Rheum"},{"key":"3768_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/acr.22458","volume":"67","author":"MC Kapetanovic","year":"2015","unstructured":"Kapetanovic MC, Lindqvist E, Nilsson J\u00c5, Geborek P, Saxne T, Eberhardt K. Development of functional impairment and disability in rheumatoid arthritis patients followed for 20 years: relation to disease activity, joint damage, and comorbidity. Arthritis Care Res (Hoboken) 2015;67:340\u2013348.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3768_CR20","first-page":"S40","volume":"34","author":"PL van Riel","year":"2016","unstructured":"van Riel PL, Renskers L. The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol 2016;34:S40\u2013S44.","journal-title":"Clin Exp Rheumatol"},{"key":"3768_CR21","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3899\/jrheum.130166","volume":"40","author":"Y Kaneko","year":"2013","unstructured":"Kaneko Y, Kondo H, Takeuchi T. American College of Rheumatology\/European League against rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints. J Rheumatol 2013;40:1254\u20131258.","journal-title":"J Rheumatol"},{"key":"3768_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13063-018-2555-1","volume":"19","author":"Q Wang","year":"2018","unstructured":"Wang Q, Wang YR, Jia QY, Liu L, Xu CQ, et al. The efficacy of the traditional Chinese medicine Juanbi Pill combined with methotrexate in active rheumatoid arthritis: study protocol for a randomized controlled trial. Trials 2018;19:188.","journal-title":"Trials"},{"key":"3768_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4078\/jrd.2024.0077","volume":"31","author":"SR Choi","year":"2024","unstructured":"Choi SR, Cho SK, Sung YK. Application of disease activity index in rheumatoid arthritis management in Korea. J Rheum Dis 2024;31:193\u2013199.","journal-title":"J Rheum Dis"},{"key":"3768_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.reuma.2016.12.001","volume":"14","author":"J Tornero Molina","year":"2018","unstructured":"Tornero Molina J, Calvo Alen J, Ballina J, Belmonte M\u00c1, Blanco FJ, et al. Recommendations for the use of parenteral methotrexate in rheumatic diseases. Reumatol Clin (Engl Ed) 2018;14:142\u2013149.","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"3768_CR25","first-page":"503","volume":"5","author":"LE Boh","year":"1986","unstructured":"Boh LE, Schuna AA, Pitterle ME, Adams EM, Sundstrom WR. Low-dose weekly oral methotrexate therapy for inflammatory arthritis. Clin Pharm 1986;5:503\u2013508.","journal-title":"Clin Pharm"},{"key":"3768_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00296-010-1370-0","volume":"30","author":"P Zhang","year":"2010","unstructured":"Zhang P, Li J, Han Y, Yu XW, Qin L. Traditional Chinese medicine in the treatment of rheumatoid arthritis: a general review. Rheumatol Int 2010;30:713\u2013718.","journal-title":"Rheumatol Int"},{"key":"3768_CR27","first-page":"331","volume":"26","author":"W He","year":"2006","unstructured":"He W, Zhang J, Gu SZ. Clinical observation on needle-sticking method for treatment of rheumatoid arthritis of wind-cold-damp retention type. Chin Acupunct Moxibust (Chin) 2006;26:331\u2013334.","journal-title":"Chin Acupunct Moxibust (Chin)"},{"key":"3768_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fimmu.2018.00234","volume":"9","author":"ZK Jia","year":"2018","unstructured":"Jia ZK, Li HY, Liang YL, Potempa LA, Ji SR, Wu Y. Monomeric C-reactive protein binds and neutralizes receptor activator of NF-\u03ba B ligand-induced osteoclast differentiation. Front Immunol 2018;9:234.","journal-title":"Front Immunol"},{"key":"3768_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2015.12.021","volume":"145","author":"IJ Cho","year":"2016","unstructured":"Cho IJ, Choi KH, Oh CH, Hwang YC, Jeong IK, et al. Effects of C-reactive protein on bone cells. Life Sci 2016;145:1\u20138.","journal-title":"Life Sci"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-024-3768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-024-3768-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-024-3768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T21:01:04Z","timestamp":1737752464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-024-3768-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3768"],"URL":"https:\/\/doi.org\/10.1007\/s11655-024-3768-7","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"4 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest, and there is no conflict of interest regarding the publication of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}